FDA Lifts Ban on Juul E-Cigarettes Sales

FDA Approves Juul E-Cigarettes for Adult Use, Marking a Major Shift

The U.S. Food and Drug Administration (FDA) has taken a significant step by authorizing Juul Labs to continue selling its e-cigarettes in the United States. This decision represents a major reversal from the agency’s previous stance, as it had previously banned the company’s products in 2022. The approval allows the sale of Juul’s original e-cigarette device along with refill cartridges available in tobacco and menthol flavors.

The FDA stated that this move was based on an extensive scientific review, which concluded that the benefits of these products for adult smokers outweigh the risks they pose to young people or adults who do not smoke. According to the agency, Juul provided evidence showing high rates of adults switching from traditional cigarettes to either the tobacco- or menthol-flavored Juul products.

It is important to note that while the FDA's authorization permits the legal marketing of these specific e-cigarette products to adults aged 21 and older, it does not imply that these products are safe or have been fully approved by the agency. The decision highlights the complex balance between public health concerns and the potential benefits for adult smokers looking to reduce harm.

Juul Labs, once a dominant force in the vaping industry, faced intense scrutiny as more young people began using its fruit and candy-flavored products. The company has consistently denied allegations that it marketed its e-cigarettes to children and teenagers. However, the FDA initially imposed a nationwide ban on Juul e-cigarettes in 2022, citing the company's failure to demonstrate that keeping its products on the market would be appropriate for public health.

The agency later suspended the ban to conduct an internal review of scientific issues in Juul’s application. Despite the pause, the FDA’s actions nearly led to the company’s bankruptcy. Juul also paid $1.7 billion to resolve thousands of lawsuits alleging that the company aggressively marketed its products to young people, contributing to a vaping crisis.

After considering Juul’s appeal for two years, the FDA formally rescinded the ban in 2024, placing the company’s application back under scientific review. All electronic cigarette products must legally have FDA authorization to be marketed, requiring companies to submit scientific evidence of public health benefits.

In response to the FDA’s decision, K.C. Crosthwaite, CEO of Juul Labs, stated, “Today’s FDA authorization of JUUL products marks an important step toward making the cigarette obsolete.” He emphasized the company’s support for the FDA’s role in regulating tobacco and nicotine products, highlighting the importance of providing Americans with access to high-quality, innovative, and responsibly marketed smoke-free nicotine products.

Despite this development, Juul is no longer the market leader it once was. The company has lost significant market share due to increased competition, including e-cigarettes illegally imported from China.

Anti-tobacco groups have expressed disappointment with the FDA’s decision, arguing that it risks reversing recent progress in reducing youth e-cigarette use. Yolonda Richardson, president and CEO of the Campaign for Tobacco-Free Kids, stated, “It is a big step in the wrong direction to authorize sales of the product that was responsible for this public health crisis in the first place.”

Ranjana Caple, senior manager of federal advocacy for the American Lung Association, added, “This is a serious misstep. Juul is responsible for the youth vaping epidemic, and its products have hooked a generation of kids on nicotine. Authorizing these products signals a stunning failure to protect public health.”